MoneyWorks4Me

Norris Medicines informs about compliances-certificate

20 Apr 2026 Evaluate
Norris Medicines has enclosed confirmation certificate received from Registrar and Transfer Agent ‘Purva Sharegistry (India)’ as per Regulation 74(5) of Securities and Exchange Board of India (Depositories and Participants) Regulations, 2018 for the quarter and year ended 31st March, 2026.

The above information is a part of company’s filings submitted to BSE.

Peers
Company Name CMP
Sun Pharma. Inds. 1738.95
Dr. Reddys Labs. 1240.85
Cipla 1320.10
Lupin 1945.85
Zydus Lifesciences 1115.15
View more..